Acetyl Tributyl Citrate, the Most Widely Used Phthalate Substitute Plasticizer, Induces Cytochrome P450 3A through Steroid and Xenobiotic Receptor

被引:72
作者
Takeshita, Akira [1 ,2 ]
Igarashi-Migitaka, Junko [3 ]
Nishiyama, Kazusa [4 ]
Takahashi, Hideyo [4 ]
Takeuchi, Yasuhiro [1 ,2 ]
Koibuchi, Noriyuki [5 ]
机构
[1] Toranomon Gen Hosp, Endocrine Ctr, Tokyo 1058470, Japan
[2] Okinaka Mem Inst Med Res, Tokyo 1058470, Japan
[3] St Marianna Univ, Dept Anat & Cell Biol, Sch Med, Kanagawa 2168511, Japan
[4] Teikyo Univ Sagamihara, Sch Pharmaceut Sci, Kanagawa 2525195, Japan
[5] Gunma Univ, Dept Integrat Physiol, Sch Med, Gunma 3718511, Japan
基金
日本学术振兴会;
关键词
plasticizer; CYP3A4; steroid and xenobiotic receptor; pharmaceutical excipient; acetyl tributyl citrate; PREGNANE-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; DRUG-INDUCED OSTEOMALACIA; VITAMIN-D; GENE-EXPRESSION; MEDIATED TRANSCRIPTION; BIOARTIFICIAL LIVER; CYP3A4; INDUCTION; METABOLISM;
D O I
10.1093/toxsci/kfr178
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Steroid and xenobiotic receptor (SXR) is activated by endogenous and exogenous chemicals including steroids, bile acids, and prescription drugs. SXR is highly expressed in the liver and intestine, where it regulates cytochrome P450 3A4 (CYP3A4), which in turn controls xenobiotic and endogenous steroid hormone metabolism. However, it is unclear whether Food and Drug Administration (FDA)-approved plasticizers exert such activity. In the present study, we evaluated the effects of FDA-approved plasticizers on SXR-mediated transcription in vitro by luciferase reporter, SXR-coactivator interaction, quantitative real-time PCR analysis of CYP3A4 expression, CYP3A4 enzyme activity assays, and SXR knockdown. Rats, treated with gavage and intraperitoneal injection of compounds, were examined for CYP3A1 expression in vivo. We found that four of eight FDA-approved plasticizers increased SXR-mediated transcription. In particular, acetyl tributyl citrate (ATBC), an industrial plasticizer widely used in products such as food wrap, vinyl toys, and pharmaceutical excipients, strongly activated human and rat SXR. ATBC increased CYP3A4 messenger RNA (mRNA) levels and enzyme activity in the human intestinal cells but not in human liver cells. Similarly, CYP3A1 mRNA levels were increased in the intestine but not the liver of ATBC-treated rats. These in vitro and in vivo results suggest that ATBC specifically induces CYP3A in the intestine by activating SXR. We suggest that ATBC-containing products be used cautiously because they may alter metabolism of endogenous steroid hormones and prescription drugs.
引用
收藏
页码:460 / 470
页数:11
相关论文
共 44 条
[1]   RIFAMPICIN AND VITAMIN-D METABOLISM [J].
BRODIE, MJ ;
BOOBIS, AR ;
DOLLERY, CT ;
HILLYARD, CJ ;
BROWN, DJ ;
MACINTYRE, I ;
PARK, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :810-814
[2]  
*CONS PROD SAF COM, 2010, REV EXP TOX DAT PHTH
[3]  
*EUR COMM, 1999, OP TOX CHAR RISKS CE
[4]   Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor [J].
Faucette, Stephanie R. ;
Sueyoshi, Tatsuya ;
Smith, Cornelia M. ;
Negishi, Masahiko ;
LeCluyse, Edward L. ;
Wang, Hongbing .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (03) :1200-1209
[5]   Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin [J].
Geick, A ;
Eichelbaum, M ;
Burk, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14581-14587
[6]  
Glass CK, 2000, GENE DEV, V14, P121
[7]   The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module [J].
Goodwin, B ;
Hodgson, E ;
Liddle, C .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1329-1339
[8]   Differential expression of p160 steroid receptor coactivators in the rat testis and epididymis [J].
Igarashi-Migitaka, J ;
Takeshita, A ;
Koibuchi, N ;
Yamada, S ;
Ohtani-Kaneko, R ;
Hirata, K .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (04) :595-604
[9]  
IMS, 2010, IMS HLTH REP US PRES
[10]   CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver [J].
Iwahori, T ;
Matsuura, T ;
Maehashi, H ;
Sugo, K ;
Saito, M ;
Hosokawa, M ;
Chiba, K ;
Masaki, T ;
Aizaki, H ;
Ohkawa, M ;
Suzuki, T .
HEPATOLOGY, 2003, 37 (03) :665-673